Voyager’s gene therapy for Parkinson’s shows promise in early data from small Phase Ib trial – Endpoints News
Endpoints News |
Voyager's gene therapy for Parkinson's shows promise in early data from small Phase Ib trial
Endpoints News Voyager Therapeutics $VYGR reported some good news from the front lines of its gene therapy clinical trial in Parkinson's, showing the company's drug might one day rescue patients from the inevitable decline associated with their response to levodopa … Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced … Voyager Therapeutics (VYGR) Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced PD |
